The Telegraph: Meet the man using AI to hunt down the world’s rarest diseases
An interview with Tim Guilliams, Co-founder and CEO of Healx, aiming to find new therapeutic solutions to cure patients with rare diseases. Tim tells how he is utilising machine learning to bring his therapies to trial. Healx was previously on…
Business Weekly: Frontier Developments named Business of the Year
The winners for the annual Business Weekly Awards have been announced. PROWLER.io, an AI technology venture, won the Cambridge Judge Business School Graduate Business of the Year award. Cambridge Judge Business School Woman Entrepreneur of the Year was awarded to…
Business Cloud: East of England Tech 50
Eight startups connected to Cambridge Judge Business School are listed in the region’s 50 most innovative technology companies. KisanHub, Healx, Arcus Global, Healthera, Sano Genetics, Speechmatics, Cambridge Spark and Audio Analytic are among the top companies in the East of…
Strategic Business Growth 2020 – applications are open
The Strategic Business Growth programme from the Cambridge Judge Entrepreneurship Centre recognises the challenges that businesses face when scaling up. We are recruiting the next cohort for February 2020. It is designed to support those companies that are determined to…
Movers and shakers
Five women associated with Cambridge Judge Business School are named in BioBeat report on 50 top women leaders and innovators in biotech. Five women associated with Cambridge Judge Business School are included in the sixth annual 50 Movers and Shakers…
Award-winning ventures
Several companies associated with Cambridge Judge Business School are honoured at the Cambridge Independent Science and Technology Awards. Several companies associated with Cambridge Judge Business School were honoured at the 2019 Cambridge Independent Science and Technology Awards announced on 30…
Funding for rare diseases startup
Healx, a company that seeks breakthroughs for rare diseases through artificial intelligence, said it had secured $56 million in Series B financing, led by venture capital firm Atomico and joined by Intel Capital, Global Brain and btov Partners. All previous investors…
The Telegraph: Rare disease drug firm Healx raises $56 million
Healx, a startup that seeks breakthroughs for rare diseases through artificial intelligence, secured $56 million in Series B financing, led by venture capital firm Atomico. The funding will be used to develop Healx’s therapeutic pipeline and to launch its global…
EU startups: 10 Cambridge-based startups to look out for in 2019 and beyond
Two ventures connected to Cambridge Judge Business School are on the list of Cambridge startups “to look out for” in 2019. Healx is seeking breakthroughs for rare diseases through artificial intelligence, and Entomics aims to convert food waste into energy.…
The Independent: Meet the drug hunters: the scientists determined to cure rare diseases
An interview with David Brown and Tim Guilliams, co-founders of the Healx startup that was on the Accelerate Cambridge programme run by the Cambridge Judge Entrepreneurship Centre. The company is looking to find new therapeutic solutions to cure patients with…